EFFICIENT SCREENING OF IO DRUG CANDIDATES

Streamlined, cost-effective and value add approach
to de-risking mechanism and drug function

Our Approach

We aim to bridge the translational gap by incorporating clinical evidence into novel assays and model systems to accelerate IND-enabling studies

Our Mission

“Our mission as a team is to be the leader in developing and providing our partners with translational systems to accelerate immuno-oncology (IO) research. We tailor our model systems to fit the needs of our partners by offering a unique set of cell chains and providing detailed reports with our findings.”

Our Objectives

  • Streamline the IND-enabling process by providing the “tool box” of cells, assays, model systems.
  • Connect the immunology “dots” in developing a drug profile for our partners.
  • Be innovative and cost-effective in our approach to services.
  • Think like a biotech

NEWS & EVENTS

Latest news and press releases

Mission Statement

“Our mission as a team is to be the leader in developing and providing our partners with translational systems to accelerate immuno-oncology (IO) research. We tailor our model systems to fit the needs of our partners by offering a unique set of cell chains and providing detailed reports with our findings.”

What is Immuno-Oncology (IO)?

Immuno-oncology is a method of immunotherapy used to target and treat various cancers. This method works in a different way than more traditional ways of fighting cancer, such as chemotherapy or radiation. IO uses the body’s own immune system to fight against cancerous cells.

null

MATCHED CELLS

HLA-matched immune cell and tumors to confirm function and mechanism
null

2D ASSAYS

Design 2D assays for quick screens and readouts
null

IMMUNE 3D®

Capture the Tumor Immune Microenvironment in evaluating drug candidates
null

IN VIVO STUDIES

Confirm your results in an in vivo model using our cell platforms

News & Events

Latest news, press releases and
upcoming appearances.

Our Blog

Check out our blog for the latest in the industry and
studies using our cell and media systems.